Microscopy

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable...

The Royal College of Pathologists is recruiting a clinical lead for diagnostic digital pathology, following its publication of a strategy suggesting the technology offers potential efficiency and quality benefits. The document is the first...

Investments in the millions of dollars for Series A funding continue to interest investors for AI in digital pathology. The most recent news coming from Fimmic out of Finland and their $6M raise most recently bringing their total to $11M....

Analyzing cellular populations within specific anatomies in brain images requires expertise in both neuroanatomy and cellular identification. This typically involves a scientist comparing experimental images with a reference atlas and...

OptraSCAN is proud to announce its trademark award of ‘On-Demand Digital Pathology’ as it disrupts the market with solutions to accelerate the adoption of digital pathology. OptraSCAN is working to eliminate the barriers of adopting...

This is the fifth in a series of CEO short interviews about their views on their company, the digital pathology market, lessons learned and perhaps a little insight into their business principles.  My personal thanks to Mr. Gholap and...